Statins May Prevent Fibrosis Risk Progression in MASLD, Study Finds
Statins may play an important role in preventing advanced fibrosis risk progression in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to findings from a recent study.1 The retrospective assessment of electronic …